Familial isolated dilated cardiomyopathy
Synonyms: Familial or idiopathic dilated cardiomyopathy
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal dominant, Autosomal recessive, Mitochondrial inheritance, X-linked recessive
- Age of onset
- All ages
- Status
- active
A rare familial cardiomyopathy characterized by the dilation of left ventricle and progressively impairing of systolic ventricular function, in the absence of abnormal loading conditions or coronary artery disease sufficient to cause global systolic impairment. The disease may cause heart failure or arrhythmia. The disease is isolated when no additional atypical cardiac or extracardiac manifestations are present.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Familial isolated dilated cardiomyopathy | Familial or idiopathic dilated cardiomyopathy |
| fr | Cardiomyopathie dilatée familiale isolée | Cardiomyopathie dilatée idiopathique ou familiale |
| de | Kardiomyopathie, dilatative familiäre | |
| es | Miocardiopatía dilatada familiar aislada | |
| it | Cardiomiopatia dilatativa familiare isolata | |
| nl | Familiale geïsoleerde gedilateerde cardiomyopathie | |
| pt | Miocardiopatia dilatada isolada familiar | |
| pl | Rodzinna lub idiopatyczna kardiomiopatia rozstrzeniowa | Rodzinna izolowana kardiomiopatia rozstrzeniowa |
| cs | Izolovaná familiární dilatační kardiomyopatie | Familiární idiopatická dilatační kardiomyopatie |
| uk | Сімейна ізольована дилатаційна кардіоміопатія | Сімейна або ідіопатична дилатаційна кардіоміопатія |
| zh | 家族性孤立型扩张型心肌病 | 家族性或特发性扩张型心肌病 |
| tr | Ailesel izole dilate kardiyomiyopati | Ailesel veya idiyopatik dilate kardiyomiyopati |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 115200 | BTNT | validated | |
| OMIM | 302045 | BTNT | validated | |
| OMIM | 600884 | BTNT | validated | |
| OMIM | 601154 | NTBT | validated | |
| OMIM | 601493 | BTNT | validated | |
| OMIM | 601494 | BTNT | validated | |
| OMIM | 604145 | BTNT | validated | |
| OMIM | 604288 | BTNT | validated | |
| OMIM | 604765 | BTNT | validated | |
| OMIM | 605582 | BTNT | validated | |
| OMIM | 606685 | BTNT | validated | |
| OMIM | 607482 | BTNT | validated | |
| OMIM | 608569 | BTNT | validated | |
| OMIM | 609909 | BTNT | validated | |
| OMIM | 609915 | BTNT | validated | |
| OMIM | 611407 | BTNT | validated | |
| OMIM | 611615 | BTNT | validated | |
| OMIM | 611878 | BTNT | validated | |
| OMIM | 611879 | BTNT | validated | |
| OMIM | 611880 | BTNT | validated | |
| OMIM | 612158 | BTNT | validated | |
| OMIM | 612877 | BTNT | validated | |
| OMIM | 613122 | BTNT | validated | |
| OMIM | 613172 | BTNT | validated | |
| OMIM | 613252 | BTNT | validated | |
| OMIM | 613286 | BTNT | validated | |
| OMIM | 613424 | BTNT | validated | |
| OMIM | 613426 | BTNT | validated | |
| OMIM | 613642 | BTNT | validated | |
| OMIM | 613694 | BTNT | validated | |
| OMIM | 613697 | BTNT | validated | |
| OMIM | 613881 | BTNT | validated | |
| OMIM | 614672 | BTNT | validated | |
| OMIM | 615184 | BTNT | validated | |
| OMIM | 615235 | BTNT | validated | |
| OMIM | 615248 | BTNT | validated | |
| OMIM | 615373 | NTBT | validated | |
| OMIM | 615396 | NTBT | validated | |
| OMIM | 615916 | BTNT | validated | |
| OMIM | 617047 | NTBT | validated | |
| OMIM | 618189 | BTNT | validated | |
| OMIM | 619371 | BTNT | validated | |
| OMIM | 619492 | BTNT | validated | |
| OMIM | 619747 | BTNT | validated | |
| OMIM | 619897 | BTNT | validated | |
| OMIM | 620203 | BTNT | validated | |
| OMIM | 620462 | BTNT | validated | |
| OMIM | 621595 | BTNT | validated | |
| ICD-10 | I42.0 | NTBT | attributed | validated |
| ICD-11 | BC43.00 | NTBT | index | validated |
| MONDO | 0015470 | E | validated | |
| MONDO | 15470 | E | validated | |
| MONDO | 700335 | E | validated | |
| UMLS | C5679590 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (3):
- ORPHA:217607Familial dilated cardiomyopathy
rare cardiac diseases; rare genetic diseases - ORPHA:207085Qualitative or quantitative defects of dystrophin
rare genetic diseases - ORPHA:506225Rare disorder potentially indicated for heart transplant
rare transplant-related disorders
No children.
Genes
55 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| SCN5A | Disease-causing germline mutation(s) (gain of function) in | Assessed | HGNC:10593 | ENSG00000183873 | 600163 | 3p22.2 | sodium voltage-gated channel alpha subunit 5 | 15466643[PMID]_22766342[PMID]_20301486[PMID] |
| BAG5 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:941 | ENSG00000166170 | 603885 | 14q32.33 | BAG cochaperone 5 | 35044787[PMID] |
| DOLK | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:23406 | ENSG00000175283 | 610746 | 9q34.11 | dolichol kinase | 22242004[PMID] |
| GET3 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:752 | ENSG00000198356 | 601913 | 19p13.13 | guided entry of tail-anchored proteins factor 3, ATPase | 31461301[PMID] |
| HAND2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:4808 | ENSG00000164107 | 602407 | 4q34.1 | heart and neural crest derivatives expressed 2 | 30217752[PMID] |
| NEXN | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:29557 | ENSG00000162614 | 613121 | 1p31.1 | nexilin F-actin binding protein | 19881492[PMID]_20301486[PMID] |
| TXNRD2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:18155 | ENSG00000184470 | 606448 | 22q11.21 | thioredoxin reductase 2 | 21247928[PMID] |
| ABCC9 | Disease-causing germline mutation(s) in | Assessed | HGNC:60 | ENSG00000069431 | 601439 | 12p12.1 | ATP binding cassette subfamily C member 9 | 15034580[PMID] |
| ACTC1 | Disease-causing germline mutation(s) in | Assessed | HGNC:143 | ENSG00000159251 | 102540 | 15q14 | actin alpha cardiac muscle 1 | 9563954[PMID]_20301486[PMID] |
| ACTN2 | Disease-causing germline mutation(s) in | Assessed | HGNC:164 | ENSG00000077522 | 102573 | 1q43 | actinin alpha 2 | 14567970[PMID]_25224718[PMID]_20301486[PMID] |
| ANKRD1 | Disease-causing germline mutation(s) in | Assessed | HGNC:15819 | ENSG00000148677 | 609599 | 10q23.31 | ankyrin repeat domain 1 | 19525294[PMID]_20301486[PMID] |
| BAG3 | Disease-causing germline mutation(s) in | Assessed | HGNC:939 | ENSG00000151929 | 603883 | 10q26.11 | BAG cochaperone 3 | 21353195[PMID]_20301486[PMID] |
| C10ORF71 | Disease-causing germline mutation(s) in | Assessed | HGNC:26973 | ENSG00000177354 | 621202 | 10q11.23 | chromosome 10 open reading frame 71 | 38950288[PMID] |
| CAP2 | Disease-causing germline mutation(s) in | Assessed | HGNC:20039 | ENSG00000112186 | 618385 | 6p22.3 | cyclase associated actin cytoskeleton regulatory protein 2 | 30518548[PMID] |
| CRYAB | Disease-causing germline mutation(s) in | Assessed | HGNC:2389 | ENSG00000109846 | 123590 | 11q23.1 | crystallin alpha B | 16483541[PMID]_16793013[PMID] |
| CSRP3 | Disease-causing germline mutation(s) in | Assessed | HGNC:2472 | ENSG00000129170 | 600824 | 11p15.1 | cysteine and glycine rich protein 3 | 14567970[PMID]_20301486[PMID] |
| DES | Disease-causing germline mutation(s) in | Assessed | HGNC:2770 | ENSG00000175084 | 125660 | 2q35 | desmin | 10430757[PMID]_20301486[PMID] |
| DMD | Disease-causing germline mutation(s) in | Assessed | HGNC:2928 | ENSG00000198947 | 300377 | Xp21.2-p21.1 | dystrophin | 14567970[PMID]_20301486[PMID] |
| DSG2 | Disease-causing germline mutation(s) in | Assessed | HGNC:3049 | ENSG00000046604 | 125671 | 18q12.1 | desmoglein 2 | 18678517[PMID]_20301486[PMID] |
| DSP | Disease-causing germline mutation(s) in | Assessed | HGNC:3052 | ENSG00000096696 | 125647 | 6p24.3 | desmoplakin | 30993396[PMID] |
| FHL2 | Disease-causing germline mutation(s) in | Assessed | HGNC:3703 | ENSG00000115641 | 602633 | 2q12.2 | four and a half LIM domains 2 | 17416352[PMID] |
| FKTN | Disease-causing germline mutation(s) in | Assessed | HGNC:3622 | ENSG00000106692 | 607440 | 9q31.2 | fukutin | 17036286[PMID] |
| FLNC | Disease-causing germline mutation(s) in | Assessed | HGNC:3756 | ENSG00000128591 | 102565 | 7q32.1 | filamin C | 28008423[PMID] |
| GATAD1 | Disease-causing germline mutation(s) in | Assessed | HGNC:29941 | ENSG00000157259 | 614518 | 7q21.2 | GATA zinc finger domain containing 1 | 21965549[PMID] |
| JPH2 | Disease-causing germline mutation(s) in | Assessed | HGNC:14202 | ENSG00000149596 | 605267 | 20q13.12 | junctophilin 2 | 31227780[PMID] |
| LAMA4 | Disease-causing germline mutation(s) in | Assessed | HGNC:6484 | ENSG00000112769 | 600133 | 6q21 | laminin subunit alpha 4 | 17646580[PMID] |
| LDB3 | Disease-causing germline mutation(s) in | Assessed | HGNC:15710 | ENSG00000122367 | 605906 | 10q23.2 | LIM domain binding 3 | 14662268[PMID]_14660611[PMID]_20301486[PMID] |
| LMNA | Disease-causing germline mutation(s) in | Assessed | HGNC:6636 | ENSG00000160789 | 150330 | 1q22 | lamin A/C | 24846508[PMID] |
| LMOD2 | Disease-causing germline mutation(s) in | Assessed | HGNC:6648 | ENSG00000170807 | 608006 | 7q31.32 | leiomodin 2 | 35082396[PMID] |
| MYBPC3 | Disease-causing germline mutation(s) in | Assessed | HGNC:7551 | ENSG00000134571 | 600958 | 11p11.2 | myosin binding protein C3 | 20215591[PMID]_20301486[PMID] |
| MYH6 | Disease-causing germline mutation(s) in | Assessed | HGNC:7576 | ENSG00000197616 | 160710 | 14q11.2 | myosin heavy chain 6 | 15998695[PMID]_20215591[PMID]_20301486[PMID] |
| MYH7 | Disease-causing germline mutation(s) in | Assessed | HGNC:7577 | ENSG00000092054 | 160760 | 14q11.2 | myosin heavy chain 7 | 11106718[PMID]_20301486[PMID] |
| MYPN | Disease-causing germline mutation(s) in | Assessed | HGNC:23246 | ENSG00000138347 | 608517 | 10q21.3 | myopalladin | 18006477[PMID]_22892539[PMID] |
| NRAP | Disease-causing germline mutation(s) in | Assessed | HGNC:7988 | 10q25.3 | nebulin related anchoring protein | 41033658[PMID] | ||
| PLN | Disease-causing germline mutation(s) in | Assessed | HGNC:9080 | ENSG00000198523 | 172405 | 6q22.31 | phospholamban | 12610310[PMID]_20301486[PMID] |
| PPCS | Disease-causing germline mutation(s) in | Assessed | HGNC:25686 | ENSG00000127125 | 609853 | 1p34.2 | phosphopantothenoylcysteine synthetase | 29754768[PMID] |
| PRDM16 | Disease-causing germline mutation(s) in | Assessed | HGNC:14000 | ENSG00000142611 | 605557 | 1p36.32 | PR/SET domain 16 | 23768516[PMID] |
| PSEN1 | Disease-causing germline mutation(s) in | Assessed | HGNC:9508 | ENSG00000080815 | 104311 | 14q24.2 | presenilin 1 | 17186461[PMID]_20301486[PMID] |
| PSEN2 | Disease-causing germline mutation(s) in | Assessed | HGNC:9509 | ENSG00000143801 | 600759 | 1q42.13 | presenilin 2 | 17186461[PMID]_20301486[PMID] |
| RAF1 | Disease-causing germline mutation(s) in | Assessed | HGNC:9829 | ENSG00000132155 | 164760 | 3p25.2 | Raf-1 proto-oncogene, serine/threonine kinase | 24777450[PMID] |
| RBM20 | Disease-causing germline mutation(s) in | Assessed | HGNC:27424 | ENSG00000203867 | 613171 | 10q25.2 | RNA binding motif protein 20 | 19712804[PMID]_20301486[PMID] |
| RPL3L | Disease-causing germline mutation(s) in | Assessed | HGNC:10351 | ENSG00000140986 | 617416 | 16p13.3 | ribosomal protein L3 like | 32514796[PMID] |
| SDHA | Disease-causing germline mutation(s) in | Assessed | HGNC:10680 | ENSG00000073578 | 600857 | 5p15.33 | succinate dehydrogenase complex flavoprotein subunit A | 20551992[PMID] |
| SGCD | Disease-causing germline mutation(s) in | Assessed | HGNC:10807 | ENSG00000170624 | 601411 | 5q33.2-q33.3 | sarcoglycan delta | 10974018[PMID]_20301486[PMID] |
| TAF1A | Disease-causing germline mutation(s) in | Assessed | HGNC:11532 | ENSG00000143498 | 604903 | 1q41 | TATA-box binding protein associated factor, RNA polymerase I subunit A | 28472305[PMID] |
| TAFAZZIN | Disease-causing germline mutation(s) in | Assessed | HGNC:11577 | ENSG00000102125 | 300394 | Xq28 | tafazzin, phospholipid-lysophospholipid transacylase | 7616547[PMID]_9382096[PMID]_20301486[PMID] |
| TCAP | Disease-causing germline mutation(s) in | Assessed | HGNC:11610 | ENSG00000173991 | 604488 | 17q12 | titin-cap | 15582318[PMID]_19412328[PMID]_20301486[PMID] |
| TMPO | Disease-causing germline mutation(s) in | Assessed | HGNC:11875 | ENSG00000120802 | 188380 | 12q23.1 | thymopoietin | 16247757[PMID]_20301486[PMID] |
| TNNC1 | Disease-causing germline mutation(s) in | Assessed | HGNC:11943 | ENSG00000114854 | 191040 | 3p21.1 | troponin C1, slow skeletal and cardiac type | 15542288[PMID]_20301486[PMID] |
| TNNI3 | Disease-causing germline mutation(s) in | Assessed | HGNC:11947 | ENSG00000129991 | 191044 | 19q13.42 | troponin I3, cardiac type | 15070570[PMID]_19590045[PMID]_20301486[PMID] |
| TNNT2 | Disease-causing germline mutation(s) in | Assessed | HGNC:11949 | ENSG00000118194 | 191045 | 1q32.1 | troponin T2, cardiac type | 11684629[PMID]_15542288[PMID]_20301486[PMID] |
| TPM1 | Disease-causing germline mutation(s) in | Assessed | HGNC:12010 | ENSG00000140416 | 191010 | 15q22.2 | tropomyosin 1 | 11273725[PMID]_20301486[PMID] |
| TTN | Disease-causing germline mutation(s) in | Assessed | HGNC:12403 | ENSG00000155657 | 188840 | 2q31.2 | titin | 11788824[PMID]_20301486[PMID] |
| VCL | Disease-causing germline mutation(s) in | Assessed | HGNC:12665 | ENSG00000035403 | 193065 | 10q22.2 | vinculin | 11815424[PMID]_20301486[PMID] |
| VEZF1 | Disease-causing germline mutation(s) in | Assessed | HGNC:12949 | ENSG00000136451 | 606747 | 17q22 | vascular endothelial zinc finger 1 | 36657711[PMID] |
Prevalence and incidence
3 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Annual incidence | 1-9 / 100 000 | 2.91 / 100 000 | Europe | Value and class | Validated | 16839424[PMID]_[EXPERT]_ ORPHANET |
| Point prevalence | 1-5 / 10 000 | 17.5 / 100 000 | Europe | Value and class | Validated | 16839424[PMID]_[EXPERT]_ ORPHANET |
| Annual incidence | 1-9 / 100 000 | 6 / 100 000 | United States | Value and class | Validated | 2766509[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
13 annotations · validated 2023-08-10| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0001644 | Dilated cardiomyopathy | |
| HP:0025169 | Left ventricular systolic dysfunction | |
| Frequent (79-30%) | ||
| HP:0011675 | Arrhythmia | |
| HP:0001635 | Congestive heart failure | |
| HP:0000969 | Edema | |
| HP:0002875 | Exertional dyspnea | |
| HP:0012378 | Fatigue | |
| HP:0012764 | Orthopnea | |
| Occasional (29-5%) | ||
| HP:0003457 | EMG abnormality | |
| HP:0100578 | Lipoatrophy | |
| HP:0003198 | Myopathy | |
| HP:0000407 | Sensorineural hearing impairment | |
| HP:0001727 | Thromboembolic stroke | |
Run the differential on the 2 obligate / very frequent terms
Annotation source: 20301486[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/154
- This record as JSON: /data/d/154.json